North America Cold Plasma Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

North America Cold Plasma Market Size

• The North America cold plasma market size was valued at USD 2.21 billion in 2025 and is expected to reach USD 6.98 billion by 2033, at a CAGR of 15.47% during the forecast period
•  This growth is largely driven by increasing adoption of cold plasma technology in medical and industrial sectors, including wound healing, sterilization, surface modification, and electronics manufacturing, supported by advanced healthcare infrastructure and strong R&D investment in North America
• Furthermore, rising demand for non‑thermal, eco‑friendly sterilization and surface treatment solutions, combined with technological advancements and expanding applications in healthcare, food safety, and semiconductor industries, is positioning cold plasma as a preferred technology for both industrial and clinical applications, thereby propelling market growth throughout the forecast period

North America Cold Plasma Market Analysis

• Cold plasma technology, providing non-thermal plasma-based solutions for sterilization, surface modification, and biomedical applications, is increasingly recognized as a critical tool in modern healthcare, industrial manufacturing, and electronics sectors due to its efficiency, eco-friendliness, and versatility
• The rising adoption of cold plasma is primarily driven by growing demand for advanced sterilization and decontamination solutions, expanding applications in wound healing and medical devices, and increasing interest in environmentally sustainable surface treatment processes
• The United States dominated the North America cold plasma market with the largest revenue share of 72.9% in 2025, supported by strong healthcare infrastructure, high R&D investments, early adoption of innovative technologies, and a robust presence of leading market players, with substantial growth in clinical and industrial implementations of cold plasma solutions across hospitals, laboratories, and manufacturing facilities
• Canada is expected to be the fastest-growing country in the North America cold plasma market during the forecast period due to rising healthcare investments, increasing adoption of advanced sterilization technologies, and expanding research initiatives in non-thermal plasma applications
• Medical segment dominated the North America cold plasma market in 2025, with a market share of 45.2% driven by its effectiveness in wound healing, sterilization of medical instruments, and compatibility with advanced healthcare practices

Report Scope and North America Cold Plasma Market Segmentation

North America Cold Plasma Market Trends

“Expansion into Medical and Industrial Sterilization Applications”

• A significant and accelerating trend in the North America cold plasma market is the expanding application in medical device sterilization and industrial surface treatment, offering non-thermal, eco-friendly, and highly efficient alternatives to conventional methods
• For instance, plasmaDerm, a leading medical cold plasma device, is used in hospitals to accelerate wound healing and sterilize surgical tools without heat, while Plasmatreat systems are deployed in industrial manufacturing for surface activation and decontamination
• Advanced cold plasma systems are increasingly integrated with smart control interfaces and sensors, enabling precise control over plasma parameters for optimized sterilization, surface treatment, and biomedical applications. For instance, some Plasmacure models allow automated parameter adjustments based on material type or treatment objective
• The integration of cold plasma technology with automated production lines and clinical workflows facilitates streamlined operations, reduces chemical usage, and enhances overall process efficiency in both healthcare and industrial settings
• This trend towards more precise, adaptable, and integrated cold plasma solutions is reshaping user expectations for sterilization and surface treatment, leading companies such as Piezo Technology to develop AI-assisted plasma devices with automated treatment modes
• The demand for cold plasma systems that offer versatility, environmental sustainability, and ease of integration is growing rapidly across medical, food safety, and electronics industries in North America, as consumers and manufacturers increasingly prioritize efficiency and safety
• Collaborations between cold plasma technology providers and research institutions are increasing, enabling the development of next-generation plasma devices tailored to specialized medical and industrial applications. For instance, joint research programs are exploring cold plasma for wound therapy and biofilm removal

North America Cold Plasma Market Dynamics

Driver

“Rising Demand for Advanced Sterilization and Surface Treatment Solutions”

• The increasing need for non-thermal sterilization, eco-friendly surface treatments, and enhanced industrial processes is a significant driver for the adoption of cold plasma technology
• For instance, in March 2025, Piezo Technology announced the launch of a new cold plasma system for rapid sterilization of medical instruments and surgical rooms, expected to drive adoption across hospitals and clinics
• As healthcare facilities and manufacturing plants seek safer, chemical-free sterilization and decontamination methods, cold plasma offers effective alternatives, reducing contamination risks and improving operational safety
• Furthermore, the growing interest in sustainable manufacturing and reduced chemical usage is making cold plasma an integral component in electronics, food processing, and biomedical industries
• High efficiency, precise control, and compatibility with automated systems are key factors propelling the adoption of cold plasma solutions in North America, with increasing deployment in both medical and industrial sectors
• Ongoing R&D, government support for innovative sterilization technologies, and rising awareness about hygiene and contamination control further contribute to the rapid growth of cold plasma adoption
• Increasing adoption of portable cold plasma devices for field medical applications and emergency sterilization creates new growth opportunities. For instance, mobile plasma units are being used in disaster relief hospitals and temporary clinics
• Partnerships with electronics and semiconductor manufacturers to integrate plasma treatment in production lines are further expanding the market. For instance, collaborations for plasma cleaning of microchips are being implemented in U.S. fabrication plants

Restraint/Challenge

“High Equipment Costs and Regulatory Compliance Requirements”

• The relatively high cost of advanced cold plasma systems compared to traditional sterilization and surface treatment methods poses a challenge for widespread adoption in smaller clinics and manufacturing units
• For instance, high initial investment in Plasmatreat and Piezo Technology devices may discourage some buyers from adopting cold plasma solutions despite long-term efficiency and eco-friendly benefits
• Compliance with stringent medical device regulations and industrial safety standards requires extensive testing and certifications, which can delay deployment and increase operational costs for manufacturers
• While technological advancements and modular systems are gradually reducing costs, the perceived premium for cold plasma solutions compared to conventional methods can still limit adoption, particularly among budget-conscious buyers
• Ensuring regulatory approval, proper training for operators, and cost-effective device options are crucial to overcoming these barriers and building confidence among healthcare and industrial users
• Overcoming these challenges through cost reduction, compliance support, and awareness campaigns will be vital for sustained market growth in North America
• Limited awareness about the capabilities and benefits of cold plasma technology among small and medium enterprises may slow adoption rates. For instance, some SMEs in food processing are still relying on chemical sterilization due to lack of knowledge
• Potential safety concerns regarding improper handling of plasma devices and operator training requirements pose additional hurdles. For instance, incorrect usage in industrial settings can reduce efficacy and raise liability concerns

North America Cold Plasma Market Scope

The market is segmented on the basis of regime type, technology, and industry.

• By Regime Type

On the basis of regime type, the North America cold plasma market is segmented into low pressure and atmospheric pressure. The low pressure segment dominated the market in 2025 with the largest revenue share, driven by its ability to deliver uniform plasma treatment under controlled vacuum conditions. Low pressure cold plasma is widely used in medical device sterilization, electronics, and semiconductor manufacturing due to its high precision and repeatability. Its controlled environment minimizes damage to sensitive materials while providing effective surface activation and sterilization. Hospitals and laboratories prefer low pressure plasma for critical applications where consistent efficacy and safety are paramount. Companies investing in advanced low pressure plasma chambers continue to enhance throughput and scalability, further cementing this segment’s dominance.

The atmospheric pressure segment is expected to witness the fastest growth from 2026 to 2033, fueled by its operational flexibility and lower cost requirements. Atmospheric pressure plasma does not require vacuum chambers, making it suitable for on-site sterilization, textile treatment, and industrial surface modification. Its rapid deployment in food safety, packaging, and polymer treatment applications is driving adoption among small and medium-sized enterprises. The ability to integrate atmospheric plasma with conveyor systems and continuous production lines enhances process efficiency. Moreover, innovations in portable atmospheric plasma devices are expanding its applications in hospitals, agriculture, and laboratories.

•  By Technology

On the basis of technology, the market is segmented into remote treatment, direct treatment, and electrode contact. The direct treatment segment dominated the market in 2025, owing to its precise control over plasma delivery and high effectiveness in sterilizing surfaces and medical devices. Direct treatment cold plasma ensures that active species directly interact with the target material, achieving rapid microbial inactivation and surface modification. It is widely applied in wound care, medical instrument sterilization, and microelectronics cleaning. Hospitals and laboratories prefer direct treatment for its reliability, consistency, and compatibility with sensitive substrates. Leading companies are enhancing this segment with automated systems and AI-assisted process controls to maximize efficiency. The direct approach also allows scalable solutions for batch or continuous industrial processes, reinforcing its market leadership.

The remote treatment segment is expected to witness the fastest growth during the forecast period, driven by demand for non-contact sterilization and surface modification solutions. Remote plasma allows safe treatment of heat-sensitive materials or products in hard-to-reach areas without direct exposure. Its adoption in food packaging, agricultural sterilization, and biomedical research is accelerating. Remote systems provide operational flexibility, allowing integration with automated lines and robotic arms for precision treatment. The rising focus on hygiene, contamination control, and non-invasive sterilization methods in hospitals and labs is fueling this segment’s expansion.

• By Industry

On the basis of industry, the market is segmented into textile, polymer and plastic, electronics and semiconductor, food and agriculture, and medical. The medical industry segment dominated the market in 2025, capturing the largest revenue share 45.2% due to the critical need for sterilization of surgical instruments, wound care applications, and hospital hygiene. Cold plasma offers a non-thermal, chemical-free method to reduce microbial contamination and accelerate healing, making it indispensable in modern healthcare. Hospitals and research laboratories are increasingly deploying cold plasma devices for effective sterilization and disinfection. The segment benefits from continuous innovation, including AI-assisted plasma treatments and portable sterilization units. The increasing incidence of hospital-acquired infections and demand for safer, faster sterilization solutions continue to drive market dominance.

The electronics and semiconductor industry segment is expected to witness the fastest growth from 2026 to 2033, driven by the rising need for precision cleaning, surface activation, and contamination control in microchip manufacturing and electronic device production. Cold plasma enables highly uniform surface treatment, improving adhesion, coating, and etching processes. Its non-thermal nature ensures sensitive electronic components are not damaged. Semiconductor fabs and electronics manufacturers are adopting cold plasma to meet increasing production standards and reduce chemical usage. Innovations in inline and automated plasma systems further accelerate growth in this segment. The segment’s rapid growth is fueled by expansion of electronics manufacturing in the U.S. and Canada, especially for advanced microelectronics and semiconductor devices.

North America Cold Plasma Market Regional Analysis

• The United States dominated the North America cold plasma market with the largest revenue share of 72.9% in 2025, supported by strong healthcare infrastructure, high R&D investments, early adoption of innovative technologies, and a robust presence of leading market players
•  Consumers and businesses in the region highly value the efficiency, eco-friendliness, and precision offered by cold plasma solutions, along with their ability to integrate with automated and smart control systems for optimized performance
• This widespread adoption is further supported by strong healthcare infrastructure, high R&D investment, early adoption of innovative technologies, and increasing awareness of contamination control, establishing cold plasma as a preferred technology in both medical and industrial sectors in North America

The U.S. Cold Plasma Market Insight

The U.S. cold plasma market captured the largest revenue share of 72.9% in 2025 within North America, fueled by the growing adoption of advanced sterilization, surface treatment, and biomedical applications. Hospitals, laboratories, and industrial facilities are increasingly relying on cold plasma solutions for eco-friendly and non-thermal sterilization processes. The rising demand for automated plasma systems, integration with AI-assisted controls, and portable devices for medical and industrial applications is further propelling market growth. Moreover, the expansion of electronics and semiconductor manufacturing in the U.S. is driving adoption of cold plasma for precise surface cleaning and modification. The growing focus on hygiene, contamination control, and regulatory compliance is significantly contributing to the market’s expansion.

Canada Cold Plasma Market Insight

The Canada cold plasma market accounted for 28% of the regional revenue in 2025 and is expected to witness rapid growth due to rising healthcare investments and increasing adoption of atmospheric pressure plasma solutions. These solutions offer operational flexibility and cost-efficiency, making them suitable for hospitals, research laboratories, and small- to medium-sized industrial facilities. Government initiatives supporting innovation in healthcare and manufacturing sectors are encouraging the deployment of cold plasma devices. Canada’s industrial sectors, including food processing, agriculture, and polymer treatment, are increasingly integrating plasma technology to improve efficiency and reduce chemical usage. Furthermore, the growing emphasis on sustainable and non-chemical sterilization methods is enhancing adoption rates.

Mexico Cold Plasma Market Insight

The Mexico cold plasma market is witnessing steady growth, driven by increasing industrial adoption and growing awareness of advanced sterilization technologies in medical and food processing sectors. Rising investments in healthcare infrastructure and regulatory support for non-thermal sterilization solutions are fueling demand. Companies are leveraging portable and atmospheric plasma systems to address hygiene and contamination challenges in hospitals, clinics, and manufacturing plants. The expanding electronics and semiconductor industry in Mexico is also contributing to demand for plasma surface treatments. Adoption is further supported by collaborations between domestic manufacturers and international technology providers.

North America Cold Plasma Market Share

The North America Cold Plasma industry is primarily led by well-established companies, including:

• Nordson Corporation (U.S.)
• Cold Plasma Group Inc. (Canada)
• Adtec Plasma Technology Co., Ltd. (Japan)
• Surfx Technologies, LLC (U.S.)
• US Medical Innovations LLC (U.S.)
• Cold Plasma Technologies (U.S.)
• Apyx Medical Corp. (U.S.)
• Enercon Industries Corporation (U.S.)
• TRI‑STAR TECHNOLOGIES (U.S.)
• Plasmatreat USA, Inc. (U.S.)
• UNIQAIR Technologies Ltd. (Canada)
• AcXys Plasma Technologies (France)
• Europlasma NV (Belgium)
• Neoplas GmbH (Germany)
• Relyon Plasma GmbH (Germany)
• Tantec A/S (Denmark)
• SOFTAL Corona & Plasma GmbH (Germany)
• Coating Plasma Innovation (France)
• Ferrarini & Benelli Srl (Italy)
• Molecular Plasma Group (Luxembourg)

What are the Recent Developments in North America Cold Plasma Market?

• In October 2025, Cold Plasma Group (CPG) was awarded its first U.S. patent for its cold plasma sterilization technology, expanding its application from cannabis sterilization to agricultural products and processing plant materials with sustainable, non‑chemical cold plasma treatment solutions
• In October 2025, BioLab Holdings, Inc. announced a strategic investment in terraplasma medical’s cold atmospheric plasma technology to support regulatory approval and commercialization of handheld cold plasma devices in the U.S., aimed at enhancing infection control and expanding clinical adoption of non‑invasive plasma‑based antimicrobial treatments
• In May 2024, Clean Crop Technologies (Massachusetts‑based) launched a commercial cold plasma seed treatment facility and secured significant purchase orders, marking a major step toward commercialization of cold plasma for agricultural seed sterilization and treatment purposes
• In April 2024, terraplasma successfully tested its cold plasma technology for water treatment, demonstrating the capability of cold atmospheric plasma to significantly reduce PFAS contamination and microorganisms in drinking water an important environmental application beyond healthcare and industrial uses
• In September 2021, the Jerome Canady Research Institute and US Medical Innovations (USMI) successfully completed Phase 1 of a multi‑center clinical trial using the Canady Helios™ cold plasma system for cancer treatment, demonstrating safety and therapeutic potential in conjugation with standard oncology therapies

SKU-20347